CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
OLMESARTAN MEDOXOMIL & HYDROCHLOROTHIAZIDE: products 21 to 27 of 27.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Olmesartan/HCTZ 40mg & 25mg TabDIN 02509628 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| Olmetec Plus 20mg & 12.5mg TabDIN 02319616 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| Olmetec Plus 40mg & 12.5mg TabDIN 02319624 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| Olmetec Plus 40mg & 25mg TabDIN 02319632 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Olmesartan/HCTZ 20mg & 12.5mg TabDIN 02526468 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Olmesartan/HCTZ 40mg & 12.5mg TabDIN 02526476 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Olmesartan/HCTZ 40mg & 25mg TabDIN 02526484 | General benefit | $0.3019per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.